Sentinels / Actor desk
Amgen
organization · Registry status: unverified
0bce822a-ba96-5849-a6a8-f02b4dd90e42
Evidence, not intent.
Public-source event mentions and stored signals. Adjacency does not establish causation, coordination, or an actor's position.
No claim of complete coverage or live monitoring.
Observation window
UTC dates, inclusive · maximum 90 days. Applies to events and anomalies only.
Recent observations / timeline
The source record
200 distinct events shown, newest first. More matches exist; narrow the dates to inspect beyond the latest 200. Headlines may be generated summaries; inspect the source before repeating a claim.
Key Events This Week: Midterms, Jobs, Earnings, Central Banks And More
Novartis Heart Drug Failure Leaves Doctors Seeking Evidence for Genetic Cholesterol Target
ABC6 Toys for Tots Drive returns to Central Ohio this holiday season
Amgen Just Gave Its Shareholders Great News | The Motley Fool
Amgen Just Gave Its Shareholders Great News | The Motley Fool
Futures Rise As Oil Slides Below $100 On Trump Iran Diplomacy Report, Tech Bounces Ahead Of Midterms
Key Events This Week: Midterms, Jobs, Earnings, Central Banks And More
VGT vs. QQQ: Which Tech ETF Is the Better Long-Term Buy? | The Motley Fool
Eli Lilly Jumped 6% After Earnings. It’s Up 68% in a Year. Where Does the Target Go Now? - AOL
Futures Rise As Oil Slides Below $100 On Trump Iran Diplomacy Report, Tech Bounces Ahead Of Midterms - ChinaTechNews.com
CytomX Therapeutics to Present at Upcoming November Investor Conferences
Business Brief: Five files to follow this week
Fresenius and WuXi Biologics enter exclusive development agreement to expand biosimilars pipeline
Jobs Numbers Due Next Week
US Midterm elections, Apple earnings, jobs data to test Wall Street after AI rout
US Stock Market prediction: S&P 500, Nasdaq, Dow Jones, Russell 2000 set for surprise opening on Monday, Apple, AMD, Palantir, Qualcomm other stocks to follow
Financial Analysis: Quantinuum (QNT) vs. Its Peers
US polls, earnings and jobs data loom for AI-wary stock market
Wall Street week ahead: All eyes on US midterm elections, jobs data; earnings from Apple, AMD and Palantir also in focus | Stock Market News
Looking For Growth, Income, and Stability? This Stock Could Offer All 3 | The Motley Fool
Looking For Growth, Income, and Stability? This Stock Could Offer All 3 | The Motley Fool
UHAS graduates 60 oncology nurses from 17 African countries
Colby instructor attends Harvard Medical School leadership summit
The FDA wants to pull its approval of a drug. It’s not so easy.
Study reveals distinct cellular and genetic differences in colorectal cancer in younger patients | Newswise
Wall Street Week Ahead: Midterm US elections, earnings, jobs data loom for AI-wary stock market
Stocks Flop to End Week
Cramer’s week ahead: Expect more volatility as tech earnings, midterms loom
U.S. Stocks Face Earnings, Midterms and Jobs Data After Friday Selloff | EconoTimes
Oncology Pharmacists Are Closing Lung Cancer Care Gaps at Safety-Net Hospitals | Pharmacy Times
Tech gets crushed, defensive stocks shine. How we're making sense of it all
TSX Tanks at Open
cnbc.com: John Butters, Zimmer Biomet, Wamsi Mohan (wb 1331 health technologies, wb 1350 pharmaceuticals)
Stocks Descend to End Week
Earnings next week: Can Apple, Palantir and AMD restore confidence?
Calendar: What investors need to know for the week ahead
MHRA Approves Icotyde Oral IL-23 Peptide for UK Psoriasis - Pharmaceutical Industry News - Zenopa UK
14 Ireland-based companies recruiting in quantum and deep tech
ABCs in Dermatology: Rethinking JAK Inhibitor Safety in Atopic Dermatitis | HCPLive
Midterm elections, earnings, jobs data loom for AI-wary market - AOL
Wall Street’s week ahead: Midterm elections, earnings, jobs data loom for AI-wary market
PRTC's Celea Appoints Paul Audhya, MD, MBA, as CMO | Company Announcement | Investegate
Research Finds Cellular, Genetic Differences in Young-Onset Colorectal Cancer
Amgen Braces for Rising Expenses Ahead of Q3 Results—Is a Profit Squeeze Looming?
T-DXd Plus Pertuzumab Improves Outcomes in HER2+ Breast Cancer With Brain Metastases | OncLive
UCLA organic chemists’ research on the Soai reaction cited in the 2026 Nobel Prize in Chemistry
AMGEN ANNOUNCES WEBCAST OF 2026 THIRD QUARTER FINANCIAL RESULTS
Labcorp (LH) stock trades up, here is why
Total Energy, ACT, Amgen at 52-Week Highs on News
AD109 Cuts AHI by 59.6% in Postmenopausal Women With OSA | HCPLive
INCB161734 Plus Chemotherapy Continues to Elicit Responses in KRAS G12D–Mutated PDAC | OncLive
Amgen Adds Former Yum! Brands CEO David Gibbs to Its Board | EconoTimes
AMGEN APPOINTS DAVID W. GIBBS TO BOARD OF DIRECTORS
ESMO ‘26: A cancer vaccine debate, Roche’s KRAS progress and Amgen’s ‘unprecedented’ data
Early ctDNA Clearance Linked to Improved Survival With Pembrolizumab Regimen in HPV-Negative HNSCC | OncLive
Protecting Bone Health During Breast Cancer Endocrine Therapy | Pharmacy Times
Lutikizumab achieves ‘rigorous bar’ for hidradenitis suppurativa response: Topline data
Best Biotech Stocks Worth Watching – October 26th
Dichotomy from Reality w/the Biggest News of the Day – Top 3 Takeaways – October 26th, 2026 | 1290 WJNO | The Brian Mudd Show
2minutemedicine.com: Amgen, Amgen (general government, uspec politics general1)
Amgen drug combined with immunotherapy extends survival in lung cancer trial
Progressive Charlestown
Dichotomy from Reality w/the Biggest News of the Day – Top 3 Takeaways – October 26th, 2026 | Vero Patriot | The Brian Mudd Show
Breakfast News: Science Strikes Back at Cancer | The Motley Fool
Immunotherapy combo extends survival for patients with aggressive small cell lung cancer, based on trial results presented by Dana-Farber at ESMO Congress 2026 | Newswise
Bioprinting 3D Human Tissue To Discover And Test New Treatments With Viscient Bio's Keith Murphy
Arrowhead Pharmaceuticals (NASDAQ:ARWR) and CRISPR Therapeutics (NASDAQ:CRSP) Financial Review
Critical Survey: Quantinuum (QNT) versus Its Peers
Hot Talk Radio | News and Information with Commentary and Streaming
Amgen’s IMDELLTRA Cuts Death Risk 58% in Small-Cell Lung Cancer Study
Amgen drug combined with immunotherapy extends survival in lung cancer trial
VanEck Biotech vs. Invesco Healthcare: Which ETF Offers More Potential for Long-Term Growth? | The Motley Fool
Amgen Inc. (AMGN) – What Are Brokerages Saying About This Stock?
Amgen vs. Gilead Sciences: Which Biotech Dividend Stock Is the Better Buy? | The Motley Fool
VanEck Biotech vs. Invesco Healthcare: Which ETF Offers More Potential for Long-Term Growth? | The Motley Fool
Amgen vs. Gilead Sciences: Which Biotech Dividend Stock Is the Better Buy? - AOL
Amgen’s IMDELLTRA Cuts Death Risk 58% in Small-Cell Lung Cancer Study
Zai Lab’s Zoci Shows 82% Response Rate in Early Lung Cancer Study
Durvalumab Plus BCG Improves DFS in Papillary-Only, BCG-Naive High-Risk NMIBC in POTOMAC | OncLive
INCA33890 Plus SOC Elicits Responses and Is Tolerable Across In First- and Third-Line MSS CRC | OncLive
Lung cancer breakthrough: drug combination cuts death risk by 58% in major trial
Amgen drug paired with immunotherapy improves survival in lung cancer trial: report
moneycontrol.com: Joaquim Bellmunt, David Fredrickson, Amgen Burton (crisislex c03 wellbeing health, crisislex c03 wellbeing health)
New Amgen drug combination shows survival gains in lung cancer trial
IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER
IMFINZI® (durvalumab) plus tarlatamab-dlle reduced the risk of death by 58% in 1st-line extensive-stage small cell lung cancer in the DeLLphi-305 Phase III trial
IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER
Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy? | The Motley Fool
Amgen drug combined with immunotherapy extends survival in lung cancer trial
Amgen Inc. $AMGN Shares Newly Purchased by Vision Financial Markets LLC
CROWN: ctDNA Analyses Help Predict Early Progression With First-Line Lorlatinib in ALK+ NSCLC | OncLive
Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer
Biotech stocks are surging. How investors can play the new drug innovation boom
Aston University-led international study finds ADHD medication unlikely to raise risk of self-harm
ACOG issues ‘long-awaited’ guidance on GLP-1s during pregnancy, lactation
Forget Chasing 7% Yields: These 5 Dividend Stocks Offer Something Different
Schwab's Dividend ETF Just Closed at a Record Without Owning a Single "Magnificent Seven" Stock | The Motley Fool
Weekly Buzz: AZN, ALVO Score FDA Nod; EYPT Cuts Jobs; RHHBY, GEHC Enter Deal; VERA Posts Trial Win
Analyzing Inhibrx Biosciences (NASDAQ:INBX) and Ligand Pharmaceuticals (NASDAQ:LGND)
Best Biotech Stocks To Keep An Eye On – October 23rd
At Amgen, Sustainability Is A Companywide Commitment
Zai Lab Limited: Zai Lab's Zocilurtatug Pelitecan (Zoci, Formerly ZL-1310) Demonstrates High Response Rates, Encouraging Durability and Well-Tolerated Safety Profile in First-Line Extensive-Stage Small Cell Lung Cancer
Invesco Pharmaceuticals ETF vs. iShares Biotechnology ETF: Which Is the Better Buy? | The Motley Fool
Amgen Foundation Tops $75 Million in Hands-On Biotechnology Education, Reaching 100,000 Students a Year
OpenAI Drug Discovery Swarm Decoded 7.7 Million Brain Cells in 32 Minutes
Amgen Massachusetts celebrates 25 years of innovation in Kendall Square
Tezepelumab sustains ‘clinical benefit’ for EoE remission, dysphagia relief at 52 weeks
Gevo Provides Business Update, Anticipates Carbon Business to Deliver Over $50 Million of Revenue in 2026
Biotech Giants vs. Emerging Innovators: Which ETF Is the Better Buy? | The Motley Fool
Critical Survey: TScan Therapeutics (NASDAQ:TCRX) and Alnylam Pharmaceuticals (NASDAQ:ALNY)
Biotech Giants vs. Emerging Innovators: Which ETF Is the Better Buy? | The Motley Fool
Comparing TScan Therapeutics (NASDAQ:TCRX) & AbbVie (NYSE:ABBV)
AbbVie (NYSE:ABBV) & TScan Therapeutics (NASDAQ:TCRX) Financial Comparison
Amgen (AMGN) Sales Grew 10%, but Can Earnings Catch Up to the Price?
Eli Lilly (LLY) Grew Revenue 48% While Prices Fell, Can Volume Keep Winning?
Gossamer Bio (NASDAQ:GOSS) & IDEAYA Biosciences (NASDAQ:IDYA) Financial Survey
Sawyer & Company Inc Makes New Investment in Amgen Inc. $AMGN
Updated hidradenitis suppurativa guidelines recommend multiple biologics, JAK inhibitors
Amgen Massachusetts celebrates 25 years of innovation in Kendall Square
Dow Jones Industrial Average Trades Near 52,500 After 1% Gain on Earnings as Futures Signal Further Strength
dailypolitical.com: United States, Amgen Inc, Takeda Pharmaceutical Company (crisislex c03 wellbeing health, tax disease hypertriglyceridemia)
Metabolic Dysfunction-Associated Steatohepatitis Clinical Trial and Competitive Landscape Expands as 180+ Companies Target New Treatment Options | DelveInsight
Dow Healthcare Rotation: Dow Outperforms as Sector Leads
Could Divarasib Challenge Existing KRAS G12C Inhibitors in Lung Cancer? | Pharmacy Times
Reaching Comprehensive Disease Control in UC, With Stefan Schreiber, MD | HCPLive
Credence Research Inc.: Biologics Market to Reach USD 755.83 Billion by 2035 - Credence Research
Mirikizumab Deep Remission in Crohn’s Disease, With Stefan Schreiber, MD | HCPLive
Obesity Clinical Trial and Competitive Landscape Surges as 200+ Companies Advance Next-Generation Therapies | DelveInsight
Lebrikizumab relieves ‘debilitating’ symptoms of hand, foot dermatitis in phase 3 study
Biotech and Pharma Industry News | BioPharma Dive
Biotech and Pharma Industry News | BioPharma Dive
Biotech and Pharma Industry News | BioPharma Dive
Boeing's Secret Weapon Isn't on the Factory Floor -- It's in the Boardroom | The Motley Fool
Boeing's Secret Weapon Isn't on the Factory Floor -- It's in the Boardroom | The Motley Fool
Wall Street Falls as Hot US Inflation Fuels Fed Rate Hike Bets - EconoTimes
cfotech.news: Jaime Robles, Alex Yakubovich, Levi Strauss Co (tax fncact chief executive officer, tax fncact leaders)
Amgen Inc. $AMGN Shares Sold by Thurston Springer Miller Herd & Titak Inc.
Biotech and Pharma Industry News | BioPharma Dive
AstraZeneca (AZN) Stock Price, News & Analysis | 24/7 Wall St.
Gevo Announces First Multi-Year Carbon Removal Credits Supply Agreement Through CEEZER
First Citizens Bank & Trust Co. Purchases 6,611 Shares of Amgen Inc. $AMGN
6,611 Amgen Inc. $AMGN Shares Acquired by First Citizens Bank & Trust Co.
Biotech and Pharma Industry News | BioPharma Dive
Blockbuster Drugs Come and Go. These 5 Pharma Dividend Stocks Keep Paying - AOL
Blockbuster Drugs Come and Go. These 5 Pharma Dividend Stocks Keep Paying
Dupilumab Improves Esophageal Diameter in EoE
Biotech and Pharma Industry News | BioPharma Dive
Rezpegaldesleukin Hair Regrowth Climbs Through 1 Year in AA: David Rosmarin, MD | HCPLive
Psoriasis clearance more than twice as likely with zasocitinib vs deucravacitinib
Medical Health & Life Science Research News
Critical Comparison: Nektar Therapeutics (NASDAQ:NKTR) versus Maze Therapeutics (NASDAQ:MAZE)
Argenx Stops Phase 3 Vyvgart Trial in Sjögren's Disease After Monitors Find the Study Cannot Meet Its Goal
Biotech and Pharma Industry News | BioPharma Dive
Biogen (BIIB) vs Amgen (AMGN) and Gilead (GILD): Which Big Pharma Stock is a Better Buy?
Biotech and Pharma Industry News | BioPharma Dive
Medical Health & Life Science Research News
Contrasting Nektar Therapeutics (NASDAQ:NKTR) and Cardiff Oncology (NASDAQ:CRDF)
Atopic Dermatitis Biologic Selection, With Raj Chovatiya, MD, PhD | HCPLive
Bausch + Lomb swaps CEOs; Merck reveals anticipated eye drug data
Bristol Myers dips on ‘confounding’ lung drug results
1st Cir. Reinstates Migraine Drug Wrongful Death Action Against Amgen
Own Both VOO and QQQM? You May Be Buying the Same Stocks Twice. | The Motley Fool
Which iShares Healthcare ETF Is the Better Buy: Biotech-Focused IBB or Broad IYH? | The Motley Fool
Atopic Dermatitis Pipeline and Remibrutinib Approval for Dermographism | HCPLive
openpr.com: Bristol Myers Squibb, Cutaneous Lupus Erythematosus Companies, Astrazeneca (medical, tax disease lupus)
Biotech and Pharma Industry News | BioPharma Dive
Contrasting Oramed Pharmaceuticals (NASDAQ:ORMP) & Generate Biomedicines (NASDAQ:GENB)
Biotech and Pharma Industry News | BioPharma Dive
How Much Would You Need to Invest in These 5 Pharma Stocks to Earn $1,000 a Month in Dividends? - AOL
How Much Would You Need to Invest in These 5 Pharma Stocks to Earn $1,000 a Month in Dividends? | The Motley Fool
Biotech and Pharma Industry News | BioPharma Dive
Veeva Systems’ (VEEV) Comeback Gets Jim Cramer Talking
Top Biotech Stocks To Watch Now – October 10th
Biotech and Pharma Industry News | BioPharma Dive
Biotech and Pharma Industry News | BioPharma Dive
How Emicizumab Changed Hemophilia A Prophylaxis, and What Comes Next | HCPLive
A Stock Market Crash Is Coming By the End of 2027, According to Some Economists. Here Are 2 Stocks to Buy Before That Happens | The Motley Fool
UBS Group Issues Positive Forecast for Amgen (NASDAQ:AMGN) Stock Price
Head to Head Comparison: Generate Biomedicines (NASDAQ:GENB) vs. Allogene Therapeutics (NASDAQ:ALLO)
Prifemilast Demonstrates Superior Efficacy vs. Apremilast in Newsoara's Head-to-Head Phase 3 Psoriasis Trial; cAMPfield Advancing the Potential Best-in-Class Oral PDE4 Inhibitor in IBD
Bayer Selects Central Ohio for $2.2 Billion Pharmaceutical Manufacturing Facility - WOWO News/Talk 92.3 FM and 1190 AM
Excalipoint raises funds for T cell therapies
Current age-based genetic testing in patients with cancer may miss majority of inherited gene variants
FDA approves Rhapsido for chronic hives inadequately controlled by antihistamines
Brodalumab Sustains Psoriasis Control for 52 Weeks
Gevo and ClimeFi Complete Carbon Removal Transaction, Advancing Gevo's Growing Carbon Business
Analyzing Generate Biomedicines (GENB) and Its Peers
Sun tops Camera’s list of Top 50 local employers
Biotech and Pharma Industry News | BioPharma Dive
Amgen (AMGN) and Johnson & Johnson (JNJ) Catch Jim Cramer’s Eye for Different Reasons
Age-Based Genetic Testing May Miss Most Inherited Variants in Cancer Patients
Venture Visionary Partners LLC Purchases 1,272 Shares of Amgen Inc. $AMGN
1,272 Amgen Inc. $AMGN Shares Purchased by Venture Visionary Partners LLC
2,093 Shares of Amgen Inc. $AMGN Bought by Canandaigua National Trust Co of Florida
AWN Jobs Roundup, October 7: 61 Animation and VFX Openings Worldwide
Biotech and Pharma Industry News | BioPharma Dive
Bayer to invest $2.2 billion in new manufacturing site in Ohio
Biotech and Pharma Industry News | BioPharma Dive
bruneinews.net: Ashita Aggarwal, Varun Nagaraj, Renuka Kamath (tax religion jain, tax religion jain)
calcuttanews.net: Renuka Kamath, Ashita Aggarwal, Varun Nagaraj (soc innovation, wb 1331 health technologies)
Signals to inspect
Anomalies
Latest 10 in the selected window (up to 10). Detector output, not verified conclusions.
New connection: 11 previously unseen co-actor(s) detected (known network: 434)
Tone shift: score -4.7 deviates 2.8σ from baseline mean 0.2 (stddev 1.75)
Volume spike: 3 events in window (2.8x baseline of 1.1 expected)
Tone shift: score -4.7 deviates 2.9σ from baseline mean 0.2 (stddev 1.71)
Volume spike: 4 events in window (3.8x baseline of 1.1 expected)
Tone shift: score -4.7 deviates 3.0σ from baseline mean 0.2 (stddev 1.66)
Tone shift: score -4.7 deviates 2.7σ from baseline mean 0.1 (stddev 1.79)
Coordination signal: co-actor a33719b8-8a68-5d30-b024-275268acb2f4 appeared in 4 of 5 window events (80%)
Tone shift: score -4.7 deviates 3.1σ from baseline mean 0.3 (stddev 1.61)
Narrative context
Unresolved threads
Latest 20 at most, across all dates. Stored narratives require human review.
Stored connections
Relationships
Up to 50 records ordered by evidence count, across all dates. Co-mentions indicate association in source material, not affiliation or coordination.
- Amgen→ co mention →Eli Lilly502 evidence records
- Amgen→ co mention →United States Senate415 evidence records
- Amgen→ co mention →Nasdaq386 evidence records
- Amgen→ co mention →Pfizer336 evidence records
- Amgen→ co mention →Novo Nordisk326 evidence records
- Amgen→ co mention →Astrazeneca310 evidence records
- Amgen→ co mention →Novartis280 evidence records
- Amgen→ co mention →Bristol Myers Squibb260 evidence records
- Amgen→ co mention →Donald Trump249 evidence records
- Amgen→ co mention →Drug Enforcement Administration198 evidence records
- Amgen→ co mention →Sun Pharmaceuticals On177 evidence records
- Amgen→ co mention →Nvidia155 evidence records
- Amgen→ co mention →White House150 evidence records
- Amgen→ co mention →Novo Wegovy141 evidence records
- Amgen→ co mention →Securities and Exchange Commission140 evidence records
- Amgen→ co mention →Lilly Zepbound139 evidence records
- Amgen→ co mention →Eboog Johnson133 evidence records
- Amgen→ co mention →Cigna Group130 evidence records
- Amgen→ co mention →Commerce Drug Company122 evidence records
- Amgen→ co mention →Boehringer Ingelheim121 evidence records
- Amgen→ co mention →Ombudsman Commission121 evidence records
- Amgen→ co mention →Genentech118 evidence records
- Amgen→ co mention →Goldman Sachs Group Inc107 evidence records
- Amgen→ co mention →S P Dow Jones100 evidence records
- Amgen→ co mention →Microsoft93 evidence records
- Amgen→ co mention →Merck Co93 evidence records
- Amgen→ co mention →Quarter For Gilead Sciences87 evidence records
- Amgen→ co mention →Serono82 evidence records
- Amgen→ co mention →Reuters82 evidence records
- Amgen→ co mention →Glaxosmithkline77 evidence records
- Amgen→ co mention →Vertex Pharmaceuticals Incorporated72 evidence records
- Amgen→ co mention →Geode Capital Management68 evidence records
- Amgen→ co mention →Federal Reserve65 evidence records
- Amgen→ co mention →Chevron65 evidence records
- Amgen→ co mention →Linkedin61 evidence records
- Amgen→ co mention →Morgan Stanley59 evidence records
- Amgen→ co mention →Caterpillar58 evidence records
- Amgen→ co mention →Mehmet Oz55 evidence records
- Amgen→ co mention →Terms Of Service54 evidence records
- Joe Gebbia→ co mention →Amgen54 evidence records
- Amgen→ co mention →Karoline Leavitt51 evidence records
- Amgen→ co mention →Abbott Laboratories49 evidence records
- Amgen→ co mention →Piper Sandler Companies48 evidence records
- Amgen→ co mention →National Automotive Design48 evidence records
- Amgen→ co mention →Space Sciences45 evidence records
- Amgen→ co mention →Unitedhealth Group41 evidence records
- Amgen→ co mention →Intel40 evidence records
- Amgen→ co mention →Google40 evidence records
- Amgen→ co mention →Youtube40 evidence records
- Amgen→ co mention →Daiichi Sankyo38 evidence records
Ask this desk
Desk analyst
Read-only questions about Amgen's stored record. Answers cite only records retrieved for that turn; a citation chip opens the existing inspection view. Absence of matches is not evidence of inactivity.
Operator sign-in is required. Sign in